Canada’s medical technology community is watching the calendar closely as Health Canada prepares to introduce a risk‑based clinical trial framework in 2025. The shift, aiming to match the level of evidence with the anticipated risk to patients, is changing how early‑stage developers think about data generation. Teams that once focused on late‑phase validation are now planning quality systems and evidence pathways from the moment prototypes are built. The goal is pragmatic: to
